Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non–germinal center B-cell–like DLBCL
Goy, Andre, Ramchandren, Radhakrishnan, Ghosh, Nilanjan, Munoz, Javier, Morgan, David S., Dang, Nam H., Knapp, Mark, Delioukina, Maria, Kingsley, Edwin, Ping, Jerry, Beaupre, Darrin M., Neuenburg, Jutta K., Ruan, Jia
Published in Blood (26.09.2019)
Published in Blood (26.09.2019)
Get full text
Journal Article
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma
Horwitz, Steven M., Kim, Youn H., Foss, Francine, Zain, Jasmine M., Myskowski, Patricia L., Lechowicz, Mary Jo, Fisher, David C., Shustov, Andrei R., Bartlett, Nancy L., Delioukina, Maria L., Koutsoukos, Tony, Saunders, Michael E., O'Connor, Owen A., Duvic, Madeleine
Published in Blood (03.05.2012)
Published in Blood (03.05.2012)
Get full text
Journal Article
Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
KIRSCHBAUM, Mark, FRANKEL, Paul, NADEMANEE, Auayporn, FORMAN, Stephen J, GANDARA, David, NEWMAN, Edward, POPPLEWELL, Leslie, ZAIN, Jasmine, DELIOUKINA, Maria, PULLARKAT, Vinod, MATSUOKA, Deron, PULONE, Bernadette, ROTTER, Arnold J, ESPINOZA-DELGADO, Igor
Published in Journal of clinical oncology (20.03.2011)
Published in Journal of clinical oncology (20.03.2011)
Get full text
Journal Article
Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma
Usmani, Saad Z, Nahi, Hareth, Legiec, Wojciech, Grosicki, Sebastian, Vorobyev, Vladimir, Spicka, Ivan, Hungria, Vania, Korenkova, Sibirina, Bahlis, Nizar J, Flogegard, Max, Bladé, Joan, Moreau, Philippe, Kaiser, Martin, Iida, Shinsuke, Laubach, Jacob, Magen, Hila, Cavo, Michele, Hulin, Cyrille, White, Darrell, De Stefano, Valerio, Lantz, Kristen, O'Rourke, Lisa, Heuck, Christoph, Delioukina, Maria, Qin, Xiang, Nnane, Ivo, Qi, Ming, Mateos, Maria-Victoria
Published in Haematologica (Roma) (01.10.2022)
Published in Haematologica (Roma) (01.10.2022)
Get full text
Journal Article
Molecular Karyotypes of Hodgkin and Reed―Sternberg Cells at Disease Onset Reveal Distinct Copy Number Alterations in Chemosensitive versus Refractory Hodgkin Lymphoma
SLOVAK, Marilyn L, BEDELL, Victoria, HSU, Ya-Hsuan, ESTRINE, Dolores B, NOWAK, Norma J, DELIOUKINA, Maria L, WEISS, Lawrence M, SMITH, David D, FORMAN, Stephen J
Published in Clinical cancer research (15.05.2011)
Published in Clinical cancer research (15.05.2011)
Get full text
Journal Article
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS
Moreau, Philippe, Chari, Ajai, Oriol, Albert, Martinez-Lopez, Joaquin, Haenel, Mathias, Touzeau, Cyrille, Ailawadhi, Sikander, Besemer, Britta, de la Rubia Comos, Javier, Encinas, Cristina, Mateos, Maria-Victoria, Salwender, Hans, Rodriguez-Otero, Paula, Hulin, Cyrille, Karlin, Lionel, Sureda Balari, Anna, Bargay, Joan, Benboubker, Lotfi, Rosiñol, Laura, Tarantolo, Stefano, Terebelo, Howard, Yang, Shiyi, Wang, Jianping, Nnane, Ivo, Qi, Ming, Kosh, Michele, Delioukina, Maria, Goldschmidt, Hartmut
Published in Blood cancer journal (New York) (07.03.2023)
Published in Blood cancer journal (New York) (07.03.2023)
Get full text
Journal Article
Allogeneic hematopoietic cell transplant with fludarabine-based reduced-intensity conditioning as treatment for advanced chronic lymphocytic leukemia
Delioukina, Maria L., Palmer, Joycelynne M., Thomas, Sandra H., Krishnan, Amrita, Stiller, Tracey, Forman, Stephen J.
Published in Leukemia & lymphoma (01.04.2011)
Published in Leukemia & lymphoma (01.04.2011)
Get full text
Journal Article
Evaluation of chronic lymphocytic leukemia by BAC-based microarray analysis
Schultz, Roger A, Delioukina, Maria, Gaal, Karl, Bedell, Victoria, Smith, David D, Forman, Stephen J, McDaniel, Lisa D, Ballif, Blake C, Shaffer, Lisa G, Slovak, Marilyn L
Published in Molecular cytogenetics (03.02.2011)
Published in Molecular cytogenetics (03.02.2011)
Get full text
Journal Article
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial
Facon, Thierry, Kumar, Shaji K, Plesner, Torben, Orlowski, Robert Z, Moreau, Philippe, Bahlis, Nizar, Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, O'Dwyer, Michael, Perrot, Aurore, Venner, Christopher P, Weisel, Katja, Mace, Joseph R, Raje, Noopur, Tiab, Mourad, Macro, Margaret, Frenzel, Laurent, Leleu, Xavier, Ahmadi, Tahamtan, Wang, Jianping, Van Rampelbergh, Rian, Uhlar, Clarissa M, Tromp, Brenda, Delioukina, Maria, Vermeulen, Jessica, Usmani, Saad Z
Published in The lancet oncology (01.11.2021)
Published in The lancet oncology (01.11.2021)
Get full text
Journal Article
First-in-human first-in-class phase 1/2a study of the next generation CDK4-selective inhibitor PF-07220060 in patients (pts) with advanced solid tumors, enriched for HR+ HER2- mBC who progressed on prior CDK4/6 inhibitors and endocrine therapy
Yap, Timothy A., Giordano, Antonio, Hamilton, Erika P., LoRusso, Patricia, Bowers, Michelle, Basu, Cynthia, Billotte, Stephane, Delioukina, Maria, Liu, Feng, Yang, Jing, Sharma, Manish
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open‐label Phase II study
Chari, Ajai, Rodriguez‐Otero, Paula, McCarthy, Helen, Suzuki, Kenshi, Hungria, Vania, Sureda Balari, Anna, Perrot, Aurore, Hulin, Cyrille, Magen, Hila, Iida, Shinsuke, Maisnar, Vladimir, Karlin, Lionel, Pour, Ludek, Parasrampuria, Dolly A., Masterson, Tara, Kosh, Michele, Yang, Shiyi, Delioukina, Maria, Qi, Ming, Carson, Robin, Touzeau, Cyrille
Published in British journal of haematology (01.03.2021)
Published in British journal of haematology (01.03.2021)
Get full text
Journal Article
Phase II trial of irinotecan in combination with amifostine in patients with advanced colorectal carcinoma
Delioukina, Maria L., Prager, Diane, Parson, Mandy, Hecht, J. Randolph, Rosen, Peter, Rosen, Lee S.
Published in Cancer (15.04.2002)
Published in Cancer (15.04.2002)
Get full text
Journal Article
Subcutaneous Daratumumab Plus Carfilzomib and Dexamethasone (D-Kd) in Relapsed/Refractory Multiple Myeloma: An Open-label, Multicenter, Phase 2 Study (PLEIADES)
Chari, Ajai, Goldschmidt, Hartmut, yang, shiyi, Kosh, Michele, Delioukina, Maria, Qi, Ming, Moreau, Philippe
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Get full text
Journal Article
Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone: Update of the Phase 3 MAIA Trial
Perrot, Aurore, Facon, Thierry, Kumar, Shaji, Plesner, Torben, Orlowski, Robert Z., Moreau, Philippe, Bahlis, Nizar J., Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, O'Dwyer, Michael E., Venner, Chris P., Weisel, Katja, Mace, Joseph R., Raje, Noopur S., Tiab, Mourad, Macro, Magaret, Frenzel, Laurent, Leleu, Xavier, Liu, Kevin, Fastenau, John, Gries, Katharine S., Ho, Kai Fai, Mistry, Pankaj, Tromp, Brenda, Delioukina, Maria, Vermeulen, Jessica, Usmani, Saad Z.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Subcutaneous Daratumumab (DARA SC) Plus Standard-of-Care (SoC) Regimens in Multiple Myeloma (MM) across Lines of Therapy in the Phase 2 Pleiades Study: Initial Results of the Dara SC Plus Carfilzomib/Dexamethasone (D-Kd) Cohort, and Updated Results for the Dara SC Plus Bortezomib/Melphalan/Prednisone (D-VMP) and Dara SC Plus Lenalidomide/Dexamethasone (D-Rd) Cohorts
Moreau, Philippe, Chari, Ajai, Haenel, Mathias, Oriol, Albert, Rodriguez-Otero, Paula, McCarthy, Helen, Suzuki, Kenshi, Hungria, Vania T.M., Sureda Balari, Anna, Clement-Filliatre, Lauriane, Hulin, Cyrille, Magen, Hila, Iida, Shinsuke, Maisnar, Vladimir, Karlin, Lionel, Pour, Luděk, Touzeau, Cyrille, Yang, Shiyi, Kosh, Michele, Delioukina, Maria, Heuck, Christoph, Goldschmidt, Hartmut
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Transplant Information Patient System (TIPS): Development of a Web-Based Bone Marrow Transplant Workflow Tool, Providing Transplant Process Automation and Efficiency
Yatawara, Mahendra, MBA, Van Strien, Patricia, RN, MSN, Dudley, Kevin, BA, Huang, Shao-Chi, BS, Abess, Lynn, MBA, Guerrero, Margarita, RN, BSN, Snoussi, Laura, RN, Caso, Carolina, B.N., R.N., CPON, Gharapetian, Seda, BSN RN NP, Uy, Leticia, RN, Delioukina, Maria, MD, Linhares, Yuliya, MD, Lill, Michael, MD, Lim, Stephen, MD
Published in Biology of blood and marrow transplantation (01.02.2014)
Published in Biology of blood and marrow transplantation (01.02.2014)
Get full text
Journal Article
Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma
Mateos, Maria-Victoria, Rigaudeau, Sophie, Basu, Supratik, Spicka, Ivan, Schots, Rik, Wrobel, Tomasz, Cook, Gordon, Beksac, Meral, Gries, Katharine S, Kudva, Anupa, Tromp, Brenda, Van Rampelbergh, Rian, Pei, Huiling, Wroblewski, Susan, Carson, Robin, Delioukina, Maria, White, Darrell
Published in Journal of oncology pharmacy practice (01.07.2023)
Published in Journal of oncology pharmacy practice (01.07.2023)
Get more information
Journal Article